GLP-1 Drug Coverage Growing For Obesity In Medicaid, But Only For Diabetes In Medicare

Coverage data from the two programs suggest Medicare beneficiaries may be more disappointed than Medicaid enrollees by the Trump Administration’s decision not to mandate the programs cover obesity drugs.

Obesity drugs will not receive the required access in government sponsored insurance ... yet. (Shutterstock)

More from Medicare

More from Geography